Sofinnova Investments, Inc. Geron Corp Call Options Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	BUY	$2.03 - $2.42 $2.63 Million - $3.14 Million	1,297,000 Added 120.98%	2,369,100 $5.73 Million
Q3 2022 Nov 08, 2022	BUY	$1.67 - $2.94 $120,407 - $211,974	72,100 Added 7.21%	1,072,100 $2.51 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $990,000 - $1.6 Million	1,000,000 New	1,000,000 $1.36 Million

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.